ADAPT Trial for mRCC - 100280

Spotlight
Video

ADAPT Trial for mRCC

onclivetv has 407 videos Subscribe Here

Loading........
Description: Dr. Figlin discusses the ongoing ADAPT trial, which examines AGS-003 with sunitinib for the treatment of patients with metastatic renal cell carcinoma (mRCC).
Shared By : onclivetv
Posted on : 07/17/15
Added : 3 years ago
Category : Kidney Cancer